Research ArticleEndocrine and Diabetes
Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice
Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa, Kazuharu Ozawa, Hitoshi Hagita, Takahiro Kawai, Minako Takeda, Tatsuo Yata, Mio Kawai, Taku Fukuzawa, Takamitsu Kobayashi, Tsutomu Sato, Yoshiki Kawabe and Sachiya Ikeda
Journal of Pharmacology and Experimental Therapeutics June 2012, 341 (3) 692-701; DOI: https://doi.org/10.1124/jpet.112.191593
Masayuki Suzuki
Kiyofumi Honda
Masanori Fukazawa
Kazuharu Ozawa
Hitoshi Hagita
Takahiro Kawai
Minako Takeda
Tatsuo Yata
Mio Kawai
Taku Fukuzawa
Takamitsu Kobayashi
Tsutomu Sato
Yoshiki Kawabe
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleEndocrine and Diabetes
Highly Specific SGLT2 Inhibitor Improves Hyperglycemia
Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa, Kazuharu Ozawa, Hitoshi Hagita, Takahiro Kawai, Minako Takeda, Tatsuo Yata, Mio Kawai, Taku Fukuzawa, Takamitsu Kobayashi, Tsutomu Sato, Yoshiki Kawabe and Sachiya Ikeda
Journal of Pharmacology and Experimental Therapeutics June 1, 2012, 341 (3) 692-701; DOI: https://doi.org/10.1124/jpet.112.191593
Research ArticleEndocrine and Diabetes
Highly Specific SGLT2 Inhibitor Improves Hyperglycemia
Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa, Kazuharu Ozawa, Hitoshi Hagita, Takahiro Kawai, Minako Takeda, Tatsuo Yata, Mio Kawai, Taku Fukuzawa, Takamitsu Kobayashi, Tsutomu Sato, Yoshiki Kawabe and Sachiya Ikeda
Journal of Pharmacology and Experimental Therapeutics June 1, 2012, 341 (3) 692-701; DOI: https://doi.org/10.1124/jpet.112.191593
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement